argenx SE | ARGX - Net Income

Stock Price
614.00
Daily Change
-2.80 -0.45%
Monthly
-14.05%
Yearly
8.67%
Q1 Forecast
598.33

argenx SE reported $532.95M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AstraZeneca USD 2.33B 207M Dec/2025
Galapagos EUR 782.15M 984.26M Dec/2025
Genmab DKK 336M 141M Jun/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 98.25M 28.72M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
UCB EUR 857M 649M Dec/2024